FH plays a prominent role in the pathogenesis of several diseases in which genetic variations in the CFH gene are associated with modifying risk and/or where complement dysregulation is central to their etiology; these include typical and atypical HUS [27, 149, 150], AMD [30] and DDD [32, 33]. This evidence concerns the gene FH and hemolytic-uremic syndrome.